Mirati Therapeutics Inc. buy Midas
Start price
10.12.20
/
50%
€197.70
Target price
10.12.21
-
Performance (%)
-27.04%
End price
09.04.21
€144.25
Summary
This prediction ended on 09.04.21 with a price of €144.25. The prediction for Mirati Therapeutics Inc. disappointed with a performance of -27.04%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2,33 % | 1,01 % | 10,41 % | 61,23 % |
| iShares Nasdaq 100 | 1,37 % | -3,61 % | 27,40 % | 80,08 % |
| iShares Nikkei 225® | 2,44 % | -7,46 % | 49,84 % | 72,35 % |
| iShares S&P 500 | 1,26 % | 0,68 % | 23,67 % | 65,89 % |
Comments by Midas for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Buy Mirati Therapeutics Inc.